Clinical Trial Update: Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating RBS2418 in subjects with advanced metastatic solid tumors; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• RBS2418

Snippet

Sponsor: Riboscience, LLC. | Conditions: Advanced Cancer | Phase 1 | Status: RECRUITING